SUBSCRIBE
SUBSCRIBE
News   Policy

CDRH Updates: Summary Information for: TAXUS(TM) Express2(TM) Paclitaxel-Eluting Coronary Stent System

October 15, 2008 | 
1 min read

Summary Information for: TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System (Monorail, MR and Over-the-Wire, OTW) - In-Stent Restenosis (ISR) Indication. Read more from the FDA.

Regulatory
MORE ON THIS TOPIC
Futuristic Cyber Abstracy Eye Background 4K
GLP-1
EU Regulators Confirm Rare Vision Loss Risk for Novo’s Semaglutide
June 6, 2025
 · 
1 min read
 · 
Annalee Armstrong
Regulatory
RFK Jr. Joins Deputies in Voicing Support for Regulatory Flexibility for Cell and Gene Therapies
June 6, 2025
 · 
2 min read
 · 
Tristan Manalac
IN PARTNERSHIP WITH IQVIA
AI’s Role in Decoding the FDA’s New Regulatory Communications
June 5, 2025
 · 
1 min read
 · 
Lori Ellis
Government
Fired HHS Staff Sue RFK Jr., Musk, Claiming Terminations Were Based on ‘Error-Ridden’ Information
June 5, 2025
 · 
2 min read
 · 
Tristan Manalac